نحوه ارسال مقاله برای چاپ و فرایند چاپ

نحوه ارسال مقاله برای چاپ و فرایند چاپ

اسلاید 1: نحوه ارسال مقاله برای چاپ و فرایند چاپدکتر محسن جانقربانیاستاد اپیدمیولوژی

اسلاید 2: مراحل آماده کردن مقالهبازنگری ضوابط مجله درباره دستنوشته

اسلاید 3: محتوا و شکل دستنوشته:صفحه عنوانصفحه چکیدهمتنسپاسگزاریارجاعهاجدولهاتصویرها

اسلاید 4: بازنگری تحریر نهائی مقالهماشین کردن مقاله طبق ضوابط مجله

اسلاید 5: تحویل مقاله به مجلهنامه ارسالی:معرفی مقالهتشریح مقالهانتخاب مجلهانتشار قبلی و تحویل مکرر مقالهشرایط انتشارحق مولفآنچه نباید در نامه ذکر کرد

اسلاید 6: نامه ارسالی:A statement of financial or other relationships that might lead to a conflict of interest, if that information is not included in the manuscript itself or in an authors’ form. A statement that the manuscript has been read and approved by all the authors, that the requirements for authorship as stated earlier in this document have been met, and that each author believes that the manuscript represents honest work if that information is not provided in another form.

اسلاید 7: نامه ارسالی:The name, address, and telephone number of the corresponding author, who is responsible for communicating with the other authors about revisions and final approval of the proofs, if that information is not included in the manuscript itself.

اسلاید 8: نامه ارسالیMany journals now provide a presubmission checklist to help the author ensure that all the components of the submission have been included. Some journals now also require that authors complete checklists for reports of certain study types (for example, the CONSORT checklist for reports of randomized, controlled trials). Authors should look to see if the journal uses such checklists, and send them with the manuscript if they are requested.

اسلاید 9: نامه ارسالیLetters of permission to reproduce previously published material, use previously published illustrations, report information about identifiable persons, or to acknowledge people for their contributions must accompany the manuscript.

اسلاید 10: بسته بندی مقاله:نامه ارسالینسخه های مقاله تصاویر نوشتن نشانی بر پاکت

اسلاید 11: ارسال با پست هواییارسال با پست الکترونیکیارسال از طریق Manuscript Central

اسلاید 12: تصمیم های سردبیرپاسخ به تصمیم سردبیر

اسلاید 13: عوامل موثر در تصمیم گیری سر دبیرتناسب مقاله با مخاطبان مجلهاهمیت پیام مقاله برای مخاطبان مجلهتازگی پیام مقالهاعتبار علمی شواهد تقویت کننده نتایج مقاله

اسلاید 14: زمان لازم برای اخذ تصمیمتصمیم ها و پاسخها پذیرش بی درنگ و مشروطرد مقالهنمونه خوانی و غلطگیری

اسلاید 15: نوزده گام در طراحی ، نگارش و نشر یک مقالهدر باب پیام مقاله تصمیم بگیرید.در باب این که آیا اصولا مقاله به نوشتن می ارزد یا خیر، تصمیم بگیرید.در باب اهمیت مقاله تصمیم بگیرید. محک “ چه حاصل؟ “ را به کار گیرید.در باب مخاطبان مقاله تصمیم بگیرید؛ محک “ چه کسی توجه خواهد کرد؟ “ را به کار ببندید.مجله ای که مقاله را برای نشر در آن مهیا خواهید کرد، برگزینید.به جستجوی متون و آثار بپردازید.دربارةَ نویسندگان تصمیم بگیرید.

اسلاید 16: مواد لازم برای نگارش و، سرانجام، نشر مقاله را فراهم آورید.پیش از شروع نوشتن طرح مقدماتی رئوس مطالب ، ساختار کامل مقاله را در نظر بگیرید و آن گاه نگارش پیش نویس را آغاز کنید.برای نوشتن نخستین پیش نویس ، طرحی خام یا طرحی مقدماتی از رئوس مطالب تهیه کنید.نخستین پیش نویس را بنویسید.در نخستین پیش نویس و پیش نویس های بعدی ( به کمک هر یک از نویسندگان همکار) تجدید نظر کنید تا آن که محتوای مقاله رضایت خاطر شما را فراهم کند. برای رسیدن به درستی ، روشنی ، کوتاهی و دلپذیری کلام ، به بازنگری نثر و شیوه نگارش خود بپردازید.

اسلاید 17: اطمینان حاصل کنید که جزئیات شیوهَ علمی را بدرستی رعایت کرده اید.بهترین حالت و شیوه ارائه جدولها و تصویرها را برگزینید.درصورت لزوم آخرین پیش نویس کامل را بازنگری و مرورکنید و آن را برای تهیه دستنوشته نهایی به ماشین نویس بسپارید.نسخه هایی ازدستنوشته و مواد وابسته ای را که قرار است به پیوست نامه ارسالی برای سردبیر مجله بفرستید، فراهم آورید.به تصمیم سردبیر پاسخ دهید. مقاله ای را که مشروط پذیرفته شده طبق خواسته مجله بازنگری کنید، مقاله ای را که پذیرفته نشده ، پس از بازنگری لازم ، برای مجله ای دیگر ارسال دارید یا اصولآ از تلاش در راه انتشار آن دست بردارید. اگر مقاله ای برای انتشار پذیرفته شد، به محض دریافت نمونه چاپی به تصحیح آن بپردازید، بسرعت آن را باز پس فرستید و منتظر نشر مقاله شوید.

اسلاید 18: Mayer B. Davidson, M.D. Editor-in-Chief, Diabetes Care 6919 E. Tenth Street, Suite B-2 Indianapolis, IN 46219 27 March 2006Dear Prof. Davidson;Thank you very much for your email and referees’ comments dated 16 March 2006 regarding our manuscript (DC06-0440R “PROSPECTIVE STUDY OF DIABETES MELLITUS AND RISK OF HIP FRACTURE: THE NURSES’ HEALTH STUDY). We attach a revised manuscript taking into account the reviewers’ comments as follows: Reviewer A Comments: This is a well done study with appropriate analyses and conclusions. Having so large a study group enables you to have an adequate sample of diabetic patients to do a strong analysis. You make a valid point that fracture prevention is an important part of the care of women with diabetes. Reply: Thank you very much.

اسلاید 19: Reviewer B Comments: This is a well-written fine article about the association between type 1 and 2 diabetes mellitus and risk of hip fracture. The authors present a conclusion that both type 1 and type 2 diabetes increase the risk of hip fracture in women. Although the authors emphasize the advantages of their huge sample size, there is however a danger of false positive finding in such a large cohort. Although the cohort was originally not planned to study hip fractures, and the authors were not there to perform any power calculations in the beginning, did the authors calculate how many women they would need to show the clinically and statistically significant difference in the rate of fractures and risk ratios? I suggest the authors remove the conclusion concerning the duration of type 2 diabetes from the conclusion section, page 13 (In summary, our...) as they have done in the abstract section. This conclusion can not be drawn due to the probably high frequency of undiagnosed type 2 diabetics. The finding is interesting but may not be included in the final conclusions.Reply: We acted on suggestion made by reviewer B and removed the conclusion regarding duration of type 2 diabetes from the conclusion section of Discussion. About sample size, this study is one of the largest cohort studies to date of a relationship between diabetes and risk of hip fracture. Regarding power analysis, on the basis of previous estimates of hip fracture incidence of 1%, we calculated that 1,225 women with type 2 diabetes and 12,250 women without diabetes would be required to provide the study with 80 percent power to detect (with a two-sided alpha of 0.05) a relative risk of hip fracture in type 2 diabetes 2.0. Regarding power analysis in type 1 diabetes, on the basis of post hoc estimates of relative risk of 6.0 for type 1 diabetes, we calculated that 84 women with type 1 diabetes and 5,796 women without diabetes would be required to provide the study with 80 percent power to detect (with a two-sided alpha of 0.05) a relative risk of hip fracture in type 1 diabetes 6.0. We did not include these power calculations because the statistical uncertainty is expressed in the 95% percent confidence interval.

اسلاید 20: Minor comments:Comment- A reader friendly addition would be to include the mean age (range) of the women at the time of the fracture data collection in 2002. Reply: We have added the following in the Results section to describe the mean age of women at the time of hip fracture: The mean (SD) age of hip fracture was 65.6 (8.3) years for nondiabetics, 65.3 (7.4) years for type 1, and 68.6 (7.2) years for type 2 diabetes.Comment- Abstract: Typo error in Research design and methods (desighn) Typo error in Results: ..the age adjusted relative risk...(risks).Reply: The English editing has been done.Comment- Introduction: Please be more careful when referring to previous studies. There are several mistakes in the references. For example, it is said in the Introduction section, first paragraph, line 12, that: ...whereas others reported no association (...23), but in the Discussion section, page 9, line 8, the same reference (23) is quoted ...type 1 diabetes was associated with increased risk of proximal humerus fractures. In the Introduction, line 13, reference 25 is quoted as ...whereas others reported no association or even an inverse relation (..25). In fact, the results in SOF revealed that the women with diabetes were at increased risk of intra-articular radial fractures, not decreased. Furthermore, in the Introduction, line 9, the reference 21 is not in the right place. Ref 21 is a study which showed an inverse association between type 2 diabetes and bone mass and fractures, not type 1 diabetes and fractures. I suggest the authors remove the Ref 21 from the line 9, and change the places of Ref 25 and 21 in the lines 12 and 13. Furthermore, I suggest the authors concentrate on their literature review more on studies that have evaluated the association between diabetes and hip fractures, not on wrist or other minor fractures. The authors state that the samples in the previous studies have been small, but for example the Swedish cohort includes 24.605 diabetic patients plus reference population and the SOF is a large population based study. They both certainly have power enough to detect a difference in risk ratios if any exists.

اسلاید 21: Reply: We acted on suggestion made by reviewer B and corrected the references accordingly and removed sentences indicate previous studies have been small.Comment- Important risk factors for hip fracture include risk factors of falling, for example balance disturbances, muscle function, functional ability, walking ability, walking speed etc. Did the questionnaires include any questions about self rated mobility, balance, muscle strength, difficulties in daily activities, difficulties in ADL or IADL due to impaired vision, fear of falling, fall history etc. If not, I suggest these will be include in future questionnaires.Reply: Unfortunately, in our database information about self rated mobility, balance, muscle strength, difficulties in daily activities, difficulties in ADL or IADL due to impaired vision, fear of falling, fall history etc. was not recorded at baseline. Some of this has been collected in more recent questionnaires and, with additional follow-up, will serve as the basis for future analyses. Comment- Analysis: At what stage and why did the authors classify the duration of type 2 diabetes into three classes? Why did you not handle the duration as a continuous variable? Reply: The classification of duration of diabetes was done after an examination of the distribution of duration to have an adequate number of person-time in each category. We believe a categorical analysis is useful because it conveys information about the actual distribution of duration in our study and also the corresponding relative risks. The analysis was also performed with duration of diabetes as continuous covariate and the result was similar. The P for trend is the analysis with duration of diabetes as a continuous variable.

اسلاید 22: Comment- Results: In the Abstract, Results section you mention the years (>=12 years), but not in the text, Results section, page 8, where you state that Women with longer duration of type 2 diabetes tended to.... Please be more precise also in the text. The abstract should be a summary of the text. In the Results, Incidence section, please refer to the Table 2.Reply: We have made the amendment according to the suggestion and the following sentence addressed in Results section: “Women with longer duration of type 2 diabetes tended to have a higher risk of fracture than did diabetics with a shorter duration (RR 3.1; 95% CI 2.3, 4.0, for ≥12 years compared to no diabetes, P for trend <0.001)”. We also referred to Table 2 in the Incidence section of Results.Comment - Conclusions, page 11, 3rd paragraph: I think the readers would appreciate more profound discussion about the possible explanations concerning the association between insulin treatment and increase risk of hip fractures. Does insulin not have an osteogenic effect as previously suggested?Reply: We have made the amendment according to the suggestion.Comment- Conclusions, last page: The sentence beginning In summary, our... is not clear. I would suggest In summary, our study indicates that women with type 1 or type 2 diabetes are at increased risk for hip fracture.Reply: We have made the changes according to the suggestion. We thank this reviewer for his/her careful reading of our manuscript and constructive suggestions.

اسلاید 23: Reviewer C Comments: These are further data based on the large prospective observational Nurses health study. This study had provided lots of valuable information re women’s health. Most of the participants are Caucasian but this acknowledged by the authors. The paper is very well written and easy to understand. It sends an important message to clinicians caring for people with diabetes. We rightly spend a lot of time and effort reducing macrovascular/renal/visual/foot complications but dont think that much about preventing the morbidity and mortality (and expense) due to fragility fracture. This may be because many diabetologists dont do bones! However, the RR for hip fracture shown here for type 1 diabetes is greater than most other recognized independent risk factors used to predict risk of fragility fracture. The study also demonstrates the increased risk in Type 2 diabetes. This is also an important clinical point. Many health care professionals tend to think that fracture risk just relates to bone density, which in people with type 2 diabetes is often not low enough to classify as osteoporosis. However most fractures occur in individuals with osteopenia (not osteoporosis) - hence the importance preventing fragility fracture by assessing and reducing falls risk in our patients with reduced vision and neuropathy. Preventing fragility fracture is like managing diabetes – it’s about education and interdisciplinary collaboration. Diabetologists should be good at it. This paper will hopefully encourage clinicians to prevent yet another unpleasant complication Reply: We thank the reviewer for his/her advice. Sincerely yours; M. Janghorbani, PhD Prof. of Epidemiology. Dept. of Nutrition Harvard School of Public Health 665 Huntington Avenue, Boston 02115 Tel 617-432-6304 Fax: 617-432-2435

اسلاید 24: Mayer B. Davidson, MD, The editor-in-chief of Diabetes Care Diabetes Care Editorial Office 6919 E. Tenth St., Suite B-2 Indianapolis, IN 46219 24 February, 2006Dear Prof. Davidson;Please find enclosed a copy of a paper entitle “PROSPECTIVE STUDY OF DIABETES MELLITUS AND RISK OF HIP FRACTURE: THE NURSES’ HEALTH STUDY” for publishing in Diabetes Care. I takes full responsibility for the data presented in this study, analysis of the data, conclusions, and conduct of the research. I had full access to data and has maintain the right to publish any and all data independent of any third party. The Ethical Review Committee of Harvard School of Public Health and Brigham and Women’s Hospital approved the study protocol. I confirm that neither the manuscript submitted nor any part of it has been published or is being considered for publication elsewhere.Would you please consider it for publication and let me know your decision.Thank you very much in advance. Sincerely yours; M. Janghorbani, PhD Prof. of Epidemiology. Dept. of Epidemiology and Biostatistics School of Public Health Isfahan University of Medical Sciences Isfahan, Iran Tel (+98)311-6688628

اسلاید 25: تاریخ:جناب آقای دکتر عزیزیسردبیر محترم مجله پژوهش در پزشکیبا سلام محترمآ، به پیوست یک نسخه از مقاله ای تحت عنوان »اعتبار سنجش های تن سنجی در تشخیص نوزادان کم وزن« جهت چاپ در آن مجله ارسال می گردد. خواهشمند است دستور فرمایید پس از بررسی های لازم اینجانب را از نتیجه مطلع نماید. ضمنآ این مقاله منحصرآ جهت چاپ در آن مجله نوشته شده و تاکنون در جایی به چاپ نرسیده یا جهت چاپ دردست بررسی نمی باشد و تا دریافت پاسخ حضرتعالی قصد انتشار آن را در سایر نشریه های ادواری ندارد. قبلآ از بذل توجه حضرتعالی سپاسگزارم.با احترام دکتر محسن جانقربانیاستاد اپیدمیولوژی

اسلاید 26: پایان